| PERIOD ENDING | 31-Dec-09 | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | | Total Revenue | 22,106 | 20,925 | 26,262 | 24,575 | | Cost of Revenue | 7,386 | 7,993 | 8,651 | 9,366 | | | Gross Profit |
-
|
-
| 17,611 | 15,209 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,314 | 7,592 | 7,927 | 7,246 | | Non Recurring |
-
|
-
| 30,363 |
-
| | Others | 1,398 | 2,289 | (23,952) | 22,568 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
|
-
| 3,273 | (14,605) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 6,008 | 3,051 | 3,273 | (14,605) | | Interest Expense | 2,824 | 2,711 | 2,691 | 2,702 | | Income Before Tax | 3,184 | 340 | 582 | (17,307) | | Income Tax Expense | 759 | (515) | (776) | (3,237) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,425 | 855 | 1,358 | (14,070) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,425 | 855 | 1,358 | (14,070) | | Preferred Stock And Other Adjustments | (397) | (397) | (397) | (432) | | | Net Income Applicable To Common Shares | $2,028 | $458 | $961 | ($14,502) |
|
1.52% Nasdaq 0.00%
Income Statement
